How do you pay?

How to pay the least

Ask for the cash price

Idvynso

We didn’t find one.

  1. Ask your pharmacy for Idvynso’s cash price, and one or two other pharmacies too.
  2. Idvynso’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Merck Patient Assistance Program. You may qualify for the program if you have a household income of $63,840 or less for individuals, $86,560 or less for couples, or $132,000 or less for a family of 4. Or call 800-727-5400.

See if you qualify 

Compare every option

Question
Brand nameIdvynso
Authorized genericdoravirine and islatravir
Regular genericdoravirine and islatravir
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Idvynso?
The original
–
–

Brand nameThe maker’s card

IDVYNSO Coupon Program

Savings card from Merck

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

The card takes up to $9,450 per patient off your co-pay.

Sign up on activatethecard.com 

Or call 1-877-264-2454.

In the maker’s words

“Eligible, privately insured patients may pay as little as $0 per prescription on each qualifying prescription.”

From the maker’s offer on activatethecard.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Idvynso itself, from the same company, sold without the brand name, and usually for less. For now Idvynso is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

IDVYNSO is a two-drug combination of doravirine, a HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), and islatravir, a nucleoside analog reverse transcriptase inhibitor (NRTI), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of virologic treatment failure and no known substitutions associated with resistance to doravirine.

Source: the FDA label for Idvynso (Merck Sharp & Dohme LLC), April 20, 2026. Full label on DailyMed 

Good to know